Profound Medical (PROF) Free Cash Flow (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.72% |
| Dec 31, 2025 | 31.70% |
| Sep 30, 2025 | 30.05% |
| Jun 30, 2025 | -65.93% |
| Mar 31, 2025 | -40.89% |
| Dec 31, 2024 | 13.87% |
| Sep 30, 2024 | -9.76% |
| Jun 30, 2024 | -37.32% |
| Mar 31, 2024 | 38.20% |
| Dec 31, 2023 | -68.95% |
| Sep 30, 2023 | 74.12% |
| Jun 30, 2023 | -387.91% |
| Mar 31, 2023 | 112.95% |
| Dec 31, 2022 | -881.62% |
| Sep 30, 2022 | -72.96% |
| Jun 30, 2022 | 370.85% |
| Mar 31, 2022 | 80.22% |
| Dec 31, 2021 | -234.25% |
| Sep 30, 2021 | 591.86% |
| Jun 30, 2021 | -195.46% |
| Sep 30, 2020 | -21.76% |
| Jun 30, 2020 | 34.13% |
| Mar 31, 2020 | -136.06% |
| Dec 31, 2019 | 697.45% |
| Sep 30, 2019 | 46.38% |
| Jun 30, 2019 | -94.16% |
| Mar 31, 2019 | 90.09% |